United Therapeutics reported $4.7M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ardelyx ARDX:US $ 0.75M 0.24M
Baxter International BAX:US $ 88M 40M
Biocryst Pharmaceuticals BCRX:US $ 23.84M 5.06M
Biogen BIIB:US $ 66.1M 0.2M
Biomarin Pharmaceutical BMRN:US $ 3.81M 0.04M
Emergent Biosolutions EBS:US $ 8.2M 0.8M
Esperion Therapeutics ESPR:US $ 14.06M 632K
Gilead Sciences GILD:US $ 238M 0M
Halozyme Therapeutics HALO:US $ 1.76M 0.3M
Insmed INSM:US $ 3.29M 8.06M
Intercept Pharmaceuticals ICPT:US $ 6.67M 8.64M
Johnson & Johnson JNJ:US $ 10M 50M
Lexicon Pharmaceuticals LXRX:US 110K 185K
Moderna Inc MRNA:US 6M 0
Omeros OMER:US $ 4.94M 10K
Pfizer PFE:US $ 322M 6M
Ptc Therapeutics PTCT:US $ 23.61M 1.01M
Regeneron Pharmaceuticals REGN:US $ 13.6M 0.5M
Sarepta Therapeutics SRPT:US $ 15.8M 0.25M
Teva Pharmaceutical TEVA:IT 238M 58M
United Therapeutics UTHR:US $ 4.7M 0M
Vertex Pharmaceuticals VRTX:US $ 14.9M 0.19M